Susanne A. Heartsill, DVM, DABVP (Canine and Feline Practice) is the Director of Companion Animal Veterinary Services at Ceva Animal Health. She joins Dr. Andy Roark to discuss Panoquell-CA1, the new drug conditionally approved for acute onset of canine pancreatitis.

This episode is sponsored and made possible ad-free by CEVA Animal Health

LINKS:

CEVA Connect: www.cevaconnect.com

PANOQUELL-CA1:

IMPORTANT SAFETY INFORMATION: The safe use of PANOQUELL®-CA1 has not been evaluated in dogs with cardiac disease, hepatic failure,

renal impairment, dogs that are pregnant, lactating, intended for breeding or puppies under 6 months of age. PANOQUELL®-CA1 should not

be used in dogs with a known hypersensitivity to fuzapladib sodium. PANOQUELL®-CA1 is a highly protein bound drug and its use with other

highly protein bound medications have not been studied. The most common side effects in the pilot field study were anorexia, digestive tract

disorders, respiratory tract disorders and jaundice. PANOQUELL®-CA1 is not for use in humans. Limited data is available on the potential

teratogenic effects of fuzapladib sodium. Therefore, anyone who is pregnant, breast feeding, or planning to become pregnant should avoid

direct contact with PANOQUELL®-CA1.

Conditionally approved by FDA pending a full demonstration of effectiveness under application number 141-567. It is a violation of Federal law to use this product other than as directed in the labeling.

Dr. Andy Roark Exam Room Communication Tool Box Team Training Course: https://drandyroark.com/on-demand-staff-training/

Dr. Andy Roark Charming the Angry Client Team Training Course: https://drandyroark.com/charming-the-angry-client/

Dr. Andy Roark Swag: drandyroark.com/shop

All Links: linktr.ee/DrAndyRoark

ABOUT OUR GUEST:

Susanne Heartsill, DVM, DABVP (Canine and Feline Practice) is a 1999 graduate of Mississippi State University College of Veterinary Medicine and is the founder of Downtown Animal Hospital in Memphis, Tennessee.

Dr. Heartsill currently serves as the Director of US Companion Animal Veterinary Services at Ceva Animal Health.

Dr. Heartsill joined Ceva as a Veterinary Services Manager and Level 3, Fear Free Certified Veterinarian in 2018. In 2020, Dr. Heartsill became the U.S. Cardiology Technical Marketing Manager for Ceva. In this role, she spearheaded the creation and implementation of cardiology education for the U.S. commercial team in preparation for the launch of CARDALISTM. Using experience gained over two decades of clinical

practice, she developed cardiology educational resources for the practicing veterinarian and played an integral part in the launch of CARDALISTM. Due to her work in cardiology for Ceva, Dr. Heartsill won the Ceva Circle of Excellence Award in 2020. She has authored and co-authored multiple publications. In 2021, she completed credentialling and is a Diplomate of the American Board of Veterinary Practitioners (DABVP) in Canine and Feline Practice. In early 2022, Dr. Heartsill was promoted to Director of US Companion Animal Veterinary Services at Ceva Animal Health.

While running her busy small animal practice, Dr. Heartsill served as a key opinion leader for several veterinary advisory councils including Virbac, Q-biotics, and Novartis Animal Health and has been a Regional Field Advocate for IDEXX Laboratories. She has lectured nationally on topics ranging from inventory control and pharmacy management to cardiology, parasitology, laser surgery, behavior, dermatology, pancreatitis and zoonotic diseases.

Dr. Heartsill was recognized by the Memphis Business Journal as one of Memphis' Top 40 under 40 and holds a city sponsored beautification award by the Memphis Blue Suede Brigade for her part in real

estate and business revitalization in the Memphis Pinch District.

Now residing with her family on their hobby farm outside of Auburn, Alabama, Dr. Heartsill enjoys horseback riding, farm life, and the great outdoors.